McKesson Canada - Chain Drug Review

Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

MMR Sign In Subscribe

McKesson Canada expands patient access to cutting-edge Radioligand Therapy in Ontario

Pharmacy

McKesson Canada expands patient access to cutting-edge Radioligand Therapy in Ontario

Radioligand therapy represents a breakthrough in nuclear medicine,

, and CDR

March 28, 2025